Patents by Inventor Alexandra Ferrier

Alexandra Ferrier has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8652785
    Abstract: The present invention relates to a method of screening for a modulator of endothelial NO synthase (eNOS) expression, a method of diagnosing a cardiovascular disease in a subject, the use of HEBP-1 for the identification of a medicament for preventing and/or treating a disease involving eNOS dysfunction, particularly a cardiovascular disease, the use of HEBP-1 for the detection of a component of eNOS signal transduction, and the use of HEBP1 for the regulation of eNOS promoter activity.
    Type: Grant
    Filed: November 27, 2009
    Date of Patent: February 18, 2014
    Assignee: Sanofi
    Inventors: Alexandra Krog, Jochen Kruip, Paulus Wohlfart, Johann Gassenhuber, Kathrin Heermeier, Hartmut Strobel, Natalie Karst, Alexandra Ferrier, Christian Viskov
  • Publication number: 20110306553
    Abstract: The present invention relates to a method of screening for a modulator of endothelial NO synthase (eNOS) expression, a method of diagnosing a cardiovascular disease in a subject, the use of HEBP-1 for the identification of a medicament for preventing and/or treating a disease involving eNOS dysfunction, particularly a cardiovascular disease, the use of HEBP-1 for the detection of a component of eNOS signal transduction, and the use of HEBP1 for the regulation of eNOS promoter activity.
    Type: Application
    Filed: November 27, 2009
    Publication date: December 15, 2011
    Applicant: SANOFI
    Inventors: Alexandra Krog, Jochen Kruip, Paulus Wohlfart, Johann Gassenhuber, Kathrin Heermeier, Hartmut Strobel, Natalie Karst, Alexandra Ferrier, Christian Viskov
  • Patent number: 7919468
    Abstract: Compounds of the following general formula (I): are provided. The compounds can be used as modulators of the proteasome activity, in the preparation of a medicament useful for the prevention or treatment of diseases wherein the proteasome is involved, such as diseases of inflammatory processes, various hematological and solid tumor cancers, immunological and autoimmune diseases, cardiac pathologies, myopathies, AIDS, cystic fibrosis, Alzheimer's and Parkinson's disease, or in the preparation of cosmetic compositions or phytosanitary compositions.
    Type: Grant
    Filed: December 22, 2005
    Date of Patent: April 5, 2011
    Assignees: Centre National de la Recherche Scientifique (C.N.R.S.), Universite Pierre et Marie Curie
    Inventors: Michèle Claude Yvonne Reboud-Ravaux, Joëlle Vidal, Sandrine Piguel, Nicolas Basse, Alexandra Ferrier-Berthelot, Maurice Pagano